If confirmed in a larger series, our data suggest that an ancillary non-invasive test for amplification of MDM2 and other DDLPS-associated genes in cell-free DNA may help with the pre-operative diagnosis when imaging or tumor biopsy is equivocal. This evidence concerns the gene MDM2 and neoplasm.